HealthEconomy
China's Innovative Drug Exports Surge to $110B in H1 2026
Chinese innovative drug out-licensing deals hit $110 billion in H1 2026 as global pharma giants rush to license Chinese innovations.
—6 min read
Tag
#Pharmaceuticals
12 articles
HealthcarePolicy
China Expands Drug Procurement with 65 New Medicines
China's 12th national drug procurement adds 65 medicines, covering 555 total, expanding affordable access to chronic disease and critical care treatments.
—4 min read
HealthEconomy
China expands drug procurement with 65 new medicines
China's 12th national drug procurement round adds 65 medicines, easing patient costs while introducing new rules to curb extreme price cuts.
—4 min read
EconomyTechnology
Robots, AI, and Innovative Drugs Lead China's Export Push
China's exports shift from EVs to robots, AI, and innovative drugs. The 'New New Three' reshape global trade amid rising US-China tech tensions.
—6 min read
Health CarePolitics
TrumpRx Falls Short: Supermarket Promise, Boutique Reality
TrumpRx launched with great fanfare but offers only 92 brand-name drugs — less than 12% of what participating companies make.
—5 min read
HealthPolicy
TrumpRx Falls Short: Drug Discount Site a Boutique
Six months after launch, TrumpRx offers just 92 brand-name drugs — under 12% of portfolios — leaving most Americans without real savings.
—5 min read
SocietyHealthcare
China OKs 601 Drugs for 2026 Medical Insurance Review
China's NHSA announces 601 drugs passed formal review for the 2026 medical insurance catalog, with a 91% pass rate and expanded access for patients.
—4 min read
Science & Technology
China's Tech Advances: AI, Drug Trials, Cell Breakthrough
China's AI token calls lead globally for 8th week, drug trials surpass 5,000, and CAS achieves artificial cell asymmetric division breakthrough.
—5 min read
Business and Economy
GSK Acquires US Cancer Biotech Nuvalent for $10.6 Billion
GSK announces its largest-ever acquisition, buying US cancer biotech Nuvalent for $10.6 billion in a major oncology push under new CEO Luke Miels.
—4 min read
HealthEconomy
China's Innovative Drug Industry at a Tipping Point: Xinhua
Xinhua calls for accelerated China innovative drug development as record BD deals top $100B and AI transforms R&D, but warns of weak basic research.
—6 min read
HealthPolitics
Belgium Rejects Wegovy Reimbursement Over Cost Concerns
Belgian Health Minister Frank Vandenbroucke refuses to reimburse weight-loss drug Wegovy, citing prohibitive costs and concerns over essential care.
—4 min read
Health & BiotechnologyEconomy
China's Biotech Surge at ASCO 2026 Challenges US Dominance
Chinese biotech firms set records at ASCO 2026 with 95 abstracts and a $10.5B Pfizer-Innovent deal, fueling concerns over US drug dominance.
—5 min read